Pollyea, D. A., Maciejewski, J. P., Roboz, G. J., Seiter, K., Scott, B. L., DeGutis, I. S., … Erba, H. P. (2022). Treatment Patterns and Outcomes of Patients with NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry. In Blood (Vol. 140, pp. 11844–11846). American Society of Hematology. https://doi.org/10.1182/blood-2022-156679

Pollyea, Daniel A., Jaroslaw P. Maciejewski, Gail J. Roboz, Karen Seiter, Bart L. Scott, Irene S. DeGutis, Pavel Kiselev, et al. “Treatment Patterns and Outcomes of Patients with NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry.” In Blood, 140:11844–46. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-156679.

Pollyea DA, Maciejewski JP, Roboz GJ, Seiter K, Scott BL, DeGutis IS, et al. Treatment Patterns and Outcomes of Patients with NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry. In: Blood. American Society of Hematology; 2022. p. 11844–6.

Pollyea, Daniel A., et al. “Treatment Patterns and Outcomes of Patients with NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 11844–46. Crossref, doi:10.1182/blood-2022-156679.

Pollyea DA, Maciejewski JP, Roboz GJ, Seiter K, Scott BL, DeGutis IS, Kiselev P, Yu E, McBride A, Heydendael W, Erba HP. Treatment Patterns and Outcomes of Patients with NPM1+ Acute Myeloid Leukemia (AML) Enrolled in the CONNECT® Myeloid Disease Registry. Blood. American Society of Hematology; 2022. p. 11844–11846.